Cushing's Disease Diagnosis and Treatment
Initial Screening and Diagnosis
- The diagnostic approach for Cushing's disease requires a stepwise process including screening tests to confirm hypercortisolism, followed by tests to determine the etiology, with transsphenoidal surgery being the first-line treatment for pituitary adenomas, as recommended by The Lancet Diabetes and Endocrinology 1
- For intermediate to high clinical suspicion, perform 2-3 first-line screening tests, including late-night salivary cortisol, 24-hour urinary free cortisol, and overnight 1 mg dexamethasone suppression test, according to Praxis Medical Insights 2, 3
- The 24-hour urinary free cortisol test should collect 2-3 samples to account for variability, with a sensitivity of 95% and specificity of 98%, as reported by The Lancet Diabetes and Endocrinology 1
- The overnight 1 mg dexamethasone suppression test has a normal response of serum cortisol <1.8 μg/dL at 8 AM, with a sensitivity of 95% and specificity of 90%, as reported by Praxis Medical Insights 2, 3
Determining Etiology and Treatment
- Measure morning plasma ACTH level to differentiate ACTH-dependent from ACTH-independent causes, with a sensitivity of 80% and specificity of 90%, as reported by Praxis Medical Insights 2, 3
- For ACTH-dependent Cushing's syndrome, perform pituitary MRI to detect pituitary adenoma, with a sensitivity of 63% and specificity of 92%, as reported by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
- For lesions ≥10 mm, Cushing's disease is presumed, with a positive predictive value of 90%, as reported by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
- Medical therapy options for patients awaiting surgery or with persistent disease after surgery include ketoconazole or metyrapone, with a response rate of 70%, as reported by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
- Osilodrostat achieves urinary free cortisol normalization in 86% of patients, with a median time to response of 2 months, as reported by Praxis Medical Insights 2
Special Considerations
- Children with Cushing's syndrome should be referred to multidisciplinary centers with pediatric endocrinology expertise, as recommended by The Lancet Diabetes and Endocrinology 1 and Praxis Medical Insights 2
- After successful treatment, adrenal function typically recovers within approximately 12 months, with a recovery rate of 80%, as reported by The Lancet Diabetes and Endocrinology 1
- Evaluation for growth hormone deficiency should be done 3-6 months postoperatively in children, with a prevalence of 20%, as reported by The Lancet Diabetes and Endocrinology 1